ISSN 1662-4009 (online)

ey0017.15-13 | (1) | ESPEYB17

15.13. Health-related quality of life in Turner syndrome and the influence of growth hormone therapy: a 20-year follow-up

E Krantz , K Landin-Wilhelmsen , P Trimpou , I Bryman , U Wide

To read the full abstract: The Journal of Clinical Endocrinology & Metabolism 2019;104:5073–5083.On a similar theme to paper 15.12, these authors studied women with Turner syndrome (TS; n =200), age range 16–78 years, between 1995 and 2018 with a focus on the impact of growth hormone (GH) therapy on health-related quality of life (HR-QoL). Despite a mean 5.7 cm increase in expected height, GH therapy was not associated wit...